Suspension for oral administration comprising amorphous tolvaptan
This invention provides a suspension for oral administration comprising particles containing amorphous tolvaptan that can inhibit or delay crystallization of amorphous tolvaptan over time in the suspension, and stably maintain high solubility of tolvaptan and excellent absorbability of tolvaptan fro...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
01.06.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!